Global Fabry Disease Treatment Market Size & Outlook
Global fabry disease treatment market, 2016-2027 (US$M)
Related Markets
Global fabry disease treatment market highlights
- The global fabry disease treatment market generated a revenue of USD 1,208.3 million in 2020 and is expected to reach USD 1,578.3 million by 2027.
- The market is expected to grow at a CAGR (2021 - 2027) of 3.9% by 2027.
- In terms of segment, fabrazyme accounted for a revenue of USD 715.5 million in 2020.
- Galafold is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2020.
- Country-wise, Japan is expected to register the highest CAGR from 2021 to 2027.
Global data book summary
| Market revenue in 2020 | USD 1,208.3 million |
| Market revenue in 2027 | USD 1,578.3 million |
| Growth rate | 3.9% (CAGR from 2020 to 2027) |
| Largest segment | Fabrazyme |
| Fastest growing segment | Galafold |
| Historical data covered | 2016 - 2019 |
| Base year for estimation | 2020 |
| Forecast period covered | 2021 - 2027 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Galafold, Fabrazyme, Replagal |
Other key industry trends
- In terms of revenue, the North America accounted for 49.8% of the global fabry disease treatment market in 2020.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2027.
- By country, Japan is the fastest growing regional market and is projected to reach USD 95.4 million by 2027.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Fabry Disease Treatment Market Scope
Fabry Disease Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global fabry disease treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to fabry disease treatment market will help companies and investors design strategic landscapes.
Fabrazyme was the largest segment with a revenue share of 59.22% in 2020. Horizon Databook has segmented the Global fabry disease treatment market based on galafold, fabrazyme, replagal covering the revenue growth of each sub-segment from 2016 to 2027.
- Global Fabry Disease Treatment Product Outlook (Revenue, USD Million, 2016-2027)
- Galafold
- Fabrazyme
- Replagal
- Lucerastat
- Pegunigalsidase alfa
- Venglustat
- Global Fabry Disease Treatment Therapy Outlook (Revenue, USD Million, 2016-2027)
- Enzyme Therapy
- Chaperon Therapy
- Sustrate Reduction
Reasons to subscribe to Global fabry disease treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global fabry disease treatment market databook
-
Our clientele includes a mix of fabry disease treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global fabry disease treatment market , including forecasts for subscribers. This global databook contains high-level insights into Global fabry disease treatment market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
Partial client list
Global fabry disease treatment market size, by regions, 2016-2027 (US$M)
Top 10 countries: Fabry disease treatment market size, 2020 (US$M)
Global fabry disease treatment market share, by product, 2020 & 2027 (%, US$M)
Fabry disease treatment market: Opportunity assessment by country
Global fabry disease treatment market, by region, 2020 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
